Home > Balance Sheet > AUROBINDO PHARMA

AUROBINDO PHARMA
Sundry Debtors

    Back to Balance Sheet
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Sundry Debtors History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Sundry Debtors ₹5,746 Cr₹4,817 Cr₹4,466 Cr₹4,012 Cr₹3,503 Cr

What is the latest Sundry Debtors ratio of AUROBINDO PHARMA ?

The latest Sundry Debtors ratio of AUROBINDO PHARMA is ₹5,746 Cr based on Mar2025 Consolidated results.
Year Sundry Debtors
Mar2025₹5,746 Cr
Mar2024₹4,817 Cr
Mar2023₹4,466 Cr
Mar2022₹4,012 Cr
Mar2021₹3,503 Cr

How is Sundry Debtors of AUROBINDO PHARMA Trending?

Years Sundry Debtors % Change
Mar2025 ₹5,746 Cr
19.29
Mar2024 ₹4,817 Cr
7.84
Mar2023 ₹4,466 Cr
11.32
Mar2022 ₹4,012 Cr
14.53
Mar2021 ₹3,503 Cr -

Compare Sundry Debtors of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹70,430.7 Cr 0.2% 0.4% -1.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹416,884.0 Cr -0.5% -1.9% -3% Stock Analytics
DIVIS LABORATORIES ₹172,442.0 Cr 1.8% 1.3% 10.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹129,770.0 Cr 1.3% 2.7% 10% Stock Analytics
CIPLA ₹120,871.0 Cr -0.2% -0.7% 1.9% Stock Analytics
DR REDDYS LABORATORIES ₹105,693.0 Cr -1% 2.5% -4.4% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

0.2%

0.4%

-1.9%

SENSEX

1%

0.6%

7.8%


You may also like the below Video Courses